Sign up for the QMED & MD+DI Daily newsletter.
During BIOMEDEVice Silicon Valley, a panel will discuss the various types of engagement that sponsors can have with FDA.
MDDI Staff
November 22, 2022
1 Min Read
Image courtesy of Araki Illustrations / Alamy Stock Photo
Engaging FDA can be a bit intimidating for some device makers. But it doesn’t have to be that way. During BIOMEDevice Silicon Valley a panel will discuss the various types of engagement that sponsors can have with FDA, along with do's and don'ts for various types of interactions and the best times to engage.
It will cover the sponsor side and FDA side of the relationship.
Panelists Include:
Isabella Schmitt, Director of Regulatory Affairs at Proxima Clinical Research & Principal at M1MedTech
Pharoah Schnieber, COO at Boomerang Medical
Scott Trevino, Senior Vice President of Cybersecurity at Trimedx
About the Author(s)
You May Also Like
